These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6372774)

  • 1. Human insulin.
    Larkins RG
    Aust N Z J Med; 1983 Dec; 13(6):647-51. PubMed ID: 6372774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children.
    Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M
    Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purity and antigenicity of the new insulin preparations].
    Fankhauser S
    Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience].
    Vitacolonna E; Consoli A; Capani F
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins.
    Home PD; Mann NP; Hutchison AS; Park R; Walford S; Murphy M; Reeves WG
    Diabet Med; 1984 Jul; 1(2):93-8. PubMed ID: 6086002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferring patients with insulin-dependent diabetes mellitus from animal-source insulins to recombinant DNA human insulin: clinical experience.
    Davidson JK
    Clin Ther; 1989; 11(3):319-30. PubMed ID: 2663162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
    Herman RJ; Chaudhary A; Szakacs CB; Woo D; Lane R; Boctor MA
    Eur J Clin Pharmacol; 1995; 48(3-4):253-8. PubMed ID: 7589050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and allergy to recombinant human insulin.
    Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC
    J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new insulins. Their characteristics and clinical indications.
    Home PD; Alberti KG
    Drugs; 1982 Nov; 24(5):401-13. PubMed ID: 6756879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.